Added Sugar Intake and Brain Structure and Function (GAINS BRAINS)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- The University of Kansas Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participated in the ADORE GAINS study (R01 DK118220).
- Age at participation 5-6 years old.
Exclusion Criteria:
- Did not participated in the ADORE GAINS study.
- Younger than 5 and older than 6.
- Autism diagnosis
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
ADORE GAINS Participants
Children's who participated in the ADORE GAINS study were invited to participate as their body composition and dietary intake was collected during their infancy and toddlerhood.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Added Sugars Intake Relationship to Brain Structure
Time Frame: Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Assess the impact of added sugars intake measured by 24-hour dietary intake on brain structure, quantified as brain volume, via an MRI 3D MPRAGE and fMRI sequencing.
Maternal dietary intake information was collected at baseline in the ADORE study between 12-20 weeks gestation.
Offspring dietary intake information was collected at 6-months, 12-months, and 24-months of age in the ADORE GAINS study.
Dietary intake, MRI, EEG, and cognition were assessed at age 5-6 years in the present study.
|
Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
|
Added Sugars Intake Relationship to Brain Function
Time Frame: Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Assess the impact of added sugars intake measured by 24-hour dietary intake on the brain's function via EEG (task-based (Go/NoGo task) event-related potentials (ERPs)) to identify brain activity related to inhibitory control, quantified by amplitude for the Go and NoGo conditions.
Maternal dietary intake information was collected at baseline in the ADORE study between 12-20 weeks gestation.
Offspring dietary intake information was collected at 6-months, 12-months, and 24-months of age in the ADORE GAINS study.
Dietary intake, MRI, EEG, and cognition were assessed at age 5-6 years in the present study.
|
Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
|
Fructose Intake Relationship to Brain Structure
Time Frame: Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Assess the impact of fructose intake measured by 24-hour dietary intake on brain structure, quantified as brain volume, via an MRI 3D MPRAGE and fMRI sequencing.
Maternal dietary intake information was collected at baseline in the ADORE study between 12-20 weeks gestation.
Offspring dietary intake information was collected at 6-months, 12-months, and 24-months of age in the ADORE GAINS study.
Dietary intake, MRI, EEG, and cognition were assessed at age 5-6 years in the present study.
|
Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
|
Fructose Intake Relationship to Brain Function
Time Frame: Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Assess the impact of fructose intake measured by 24-hour dietary intake on the brain's function via EEG (task-based (Go/NoGo task) event-related potentials (ERPs)) to identify brain activity related to inhibitory control, quantified by amplitude for the Go and NoGo conditions.
Maternal dietary intake information was collected at baseline in the ADORE study between 12-20 weeks gestation.
Offspring dietary intake information was collected at 6-months, 12-months, and 24-months of age in the ADORE GAINS study.
Dietary intake, MRI, EEG, and cognition were assessed at age 5-6 years in the present study.
|
Day 1 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Added Sugars Intake Relationship to Cognition Specifically Attention Development
Time Frame: Day 7 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Assess the impact of added sugars intake measured by 24-hour dietary intake on cognition via a Dimensional Change Card Sort (DCCS) task measuring attention development.
Maternal dietary intake information was collected at baseline in the ADORE study between 12-20 weeks gestation.
Offspring dietary intake information was collected at 6-months, 12-months, and 24-months of age in the ADORE GAINS study.
Dietary intake, MRI, EEG, and cognition were assessed at age 5-6 years in the present study.
|
Day 7 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
|
Added Sugars Intake Relationship to Cognition Specifically Vocabulary Receptiveness
Time Frame: Day 7 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Assess the impact of added sugars intake measured by 24-hour dietary intake on cognition via Peabody Picture Vocabulary Test measuring vocabulary receptiveness.
Maternal dietary intake information was collected at baseline in the ADORE study between 12-20 weeks gestation.
Offspring dietary intake information was collected at 6-months, 12-months, and 24-months of age in the ADORE GAINS study.
Dietary intake, MRI, EEG, and cognition were assessed at age 5-6 years in the present study.
|
Day 7 in the present study (age 5-6 years old); Baseline, 6 months, 12 months and 24 months in the ADORE GAINS study; Baseline (12-20 weeks gestation) in the ADORE study;
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Holly Hull, PhD, The University of Kansas Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- STUDY00149236
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.